Fly News Breaks for August 17, 2018
SPLK
Aug 17, 2018 | 08:52 EDT
Wedbush analyst Steve Koenig said his checks with Splunk partners point to continued sales momentum, with minimal competition, in enterprise accounts. He's also hearing "excitement" around Phantom and street expectations don't appear to incorporate the potential upside from Phantom, according to Koenig. The analyst, who said he expects "clean beats in upcoming quarters" from Splunk, keeps an Outperform rating and $124 price target on the shares ahead of the company's Q2 report due on Thursday, August 23.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
